Skip to main content

Animations

MJFF Publications

5941 - 5950 of 8761 Results
Title
Year
  • Year
  • 2025
  • 2025
  • 2016
  • 2008
  • 2024
  • 2020
  • 2016
  • 2023
  • 2020
  • 2020
  • Summary Details
    RESTRICTED
    Title: Effect of dopaminergic medications on Montreal Cognitive Assessment in Parkinson's disease patients
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107951
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized Trial
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.70028
    Citation Count: 0
  • Summary Details
    OPEN
    Title: CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-016-1552-2
    Citation Count: 199
  • Summary Details
    RESTRICTED
    Title: Allosteric modulation of mGluR4 as a novel therapeutic direction for the treatment of Parkinson's disease
    Journal Name: The FASEB Journal
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1096/fasebj.22.1_supplement.103.2
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Aplp1 interacts with Lag3 to facilitate transmission of pathologic α-synuclein
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-024-49016-3
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson's disease
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.10.019
    Citation Count: 30
  • Summary Details
    OPEN
    Title: shRNA-Based Screen Identifies Endocytic Recycling Pathway Components That Act as Genetic Modifiers of Alpha-Synuclein Aggregation, Secretion and Toxicity
    Journal Name: PLOS Genetics
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pgen.1005995
    Citation Count: 80
  • Summary Details
    OPEN
    Title: Genome‐Wide Analysis of Structural Variants in Parkinson Disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/ana.26608
    Citation Count: 26
  • Summary Details
    RESTRICTED
    Title: Advantages of timing the duration of a freezing of gait-provoking test in individuals with Parkinson’s disease
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00415-020-09856-7
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Alterations of Brain Signal Oscillations in Older Individuals with HIV Infection and Parkinson’s Disease
    Journal Name: Journal of Neuroimmune Pharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s11481-020-09914-x
    Citation Count: 6
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.